Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06036420 · ClinicalTrials.gov registry record · NA
Flashed Light Therapy for Adolescents With ADHD and Delayed Sleep Timing
A NA study of ADHD, sponsored by University of California, Los Angeles.
- Active
- Registry status
- NA
- Development phase
- 6
- Enrollment target
- 1
- Study location
NCT06036420: Active NA study of ADHD, sponsored by University of California, Los Angeles.
NCT06036420 is a NA study of ADHD that is active but no longer recruiting, run by University of California, Los Angeles. The registered enrollment target is 6 participants, below the 190-participant average among 75 other ADHD trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06036420, a NA study of ADHD, is active but no longer recruiting, sponsored by University of California, Los Angeles.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary aim of the present research project is to examine the feasibility, as measured by treatment perceptions, and tolerability, as measured by adherence and attrition, of two weeks of flashed light therapy alone followed by four weeks of daily flashed light therapy combined with four weekly videoconference-delivered cognitive behavioral therapy sessions targeting circadian rhythms and sleep in four adolescents aged 14 to 17 years with attention-deficit/hyperactivity disorder and delayed sleep-wake schedules.
Primary Outcome
Child rating of how acceptable they find the treatment to be on a scale from 1 (very unacceptable) to 7 (very acceptable).
Conditions Studied
Interventions
- DEVICE Flashed Light Therapy
- BEHAVIORAL Videoconference-delivered Cognitive Behavioral Therapy
Study Locations (1)
California
- Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2023-10-20 |
| Est. Completion | 2027-03-20 |
| Phase | NA |
What the registry record for NCT06036420 still lists
NCT06036420 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 190-participant average among 75 other ADHD trials with a reported enrollment target (97% lower).
The record links to 1 condition, with ADHD appearing as the primary indexed condition, and to 2 interventions - of which Flashed Light Therapy is the first listed.
NCT06036420 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06036420 about?
NCT06036420 is a clinical study titled "Flashed Light Therapy for Adolescents With ADHD and Delayed Sleep Timing". The primary aim of the present research project is to examine the feasibility, as measured by treatment perceptions, and tolerability, as measured by adherence and attrition, of two weeks of flashed light therapy alone followed by four weeks of daily flashed light therapy combined with four weekly v...
What is the current status of trial NCT06036420?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 6 participants. The study started on 2023-10-20. Estimated completion is 2027-03-20.
What conditions does trial NCT06036420 study?
This clinical trial studies the following conditions: ADHD.
What interventions are being tested in trial NCT06036420?
The interventions under investigation include: Flashed Light Therapy (DEVICE), Videoconference-delivered Cognitive Behavioral Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT06036420?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06036420 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for ADHD
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06036420's enrollment target sits among peer trials
6 75th of 75 the lowest of 75 other ADHD trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other ADHD trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Comparative Efficacy of Organizational Skills Training (OST) and Mindfulness-Based Intervention (MBI)
RECRUITING · NA
-
Target ADHD Executive Working Memory Replication Study
RECRUITING · NA
-
Comparative Efficacy of Organizational Skills Training (OST) and Mindfulness-Based Intervention (MBI)
RECRUITING · NA
-
Fidgeting and Attentional and Emotional Regulation in ADHD
RECRUITING · NA
-
Moms Managing Attention-Deficit/Hyperactivity Disorder (ADHD) Study
RECRUITING · NA
-
A Pilot Study of a Remote ADHD Monitoring Program
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI